EARLY RELEASE: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022

Published on November 22, 2022

This report describes the vaccine effectiveness of an updated (bivalent) booster dose in people who have completed their primary series.